Thursday, February 23, 2017 7:26:31 PM
2 patients were partial responders and 1 patient had a complete response by the 9th month of treatment. The 1 partial responder is only at the 6 month stage so may become a complete responder with further treatments. The 1 partial responder at 12 months seems to be responding slower than the other responders. So this could mean that patients that do respond to the combo therapy are slowly becoming complete responders by the one year mark.
The 2 partial responders are continuing on so the next data readout will be critical.
It is amazing that Oncosec is getting a response in patients that have 100% failure to pd-1 monotherapy.
This is big and the market doesn't care today. So we need more patient data going forward which I believe we will get later on in this trial which will be enough positive data to get the green light for the registration trial.
Recent ONCSQ News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 07:30:19 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM